This scholarship page was last updated on 01 March 2022. Some details may have changed since then. Please check the Department of Health and Human Services National Institutes of Health website or the Department of Health and Human Services National Institutes of Health page for current opportunities.

Noncoding RNAs in Alzheimers Disease and Related Dementias (R21 Clinical Trial Not Allowed)

Department of Health and Human Services National Institutes of Health
Posted on:

Application Deadline:

Expired

Type

Research/project funding

Reference Number

RFA-AG-23-011

The goal of this Funding Opportunity Announcement (FOA) is to stimulate research in noncoding ribonucleic acids (ncRNAs) to investigate the causality, directionality, mechanisms, and therapeutic potential of ncRNAs implicated in Alzheimer's disease and Alzheimer's disease related dementias (AD/ADRD). This FOA will support exploratory and developmental Grant (R21) applications seeking to discover functional roles of ncRNAs and underlying mechanisms involved in the pathogenesis and progression of AD/ADRD. Proposed studies should focus on functional characterization and mechanistic investigation of previously identified ncRNAs.
Categories: Health.

More Information

Posted on:

Application Deadline:

Expired

Type

Research/Project Funding

Reference Number

RFA-AG-23-011

United States